Emerging studies suggest that pressurised oxygen therapy may slow biological aging at the telomere level, the cellular timekeepers that determine how long our tissues stay young.
A growing body of clinical research is pointing to hyperbaric oxygen therapy as a meaningful intervention in the fight against cellular aging. In a landmark Israeli study, participants undergoing a structured HBOT protocol showed measurable lengthening of their telomeres, the protective caps on chromosomes that shorten with age, along with a reduction in senescent cell populations.
These findings hint at something quietly profound: that age-related decline may not be fully inevitable. Paired with exercise, nutrition, and sleep, HBOT is now part of the toolkit longevity-focused clinicians are watching closely.
Continue reading
